IIM
IGMS

INTECH Investment Management’s IGM Biosciences IGMS Stock Holding History

INTECH Investment Management’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,069
Closed -$12.7K – 2562
2025
Q1 		$12.7K Buy
+11,069
New +$20.6K ﹤0.01% 2515

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

INTECH Investment Management's IGMS Position: Q2 2025 in Review

INTECH Investment Management sold out of IGM Biosciences (IGMS) in Q2 2025, closing a stake of 11,069 shares — an estimated $12.7K sold.

INTECH Investment Management first reported a position in IGMS in Q1 2025 and held it in 1 quarter. The position peaked at $12.7K in Q1 2025. 66 funds tracked by Wall St. Rank hold IGMS as of Q2 2025.

  • INTECH Investment Management reported no remaining IGM Biosciences position as of Q2 2025 after selling out during the quarter.
  • INTECH Investment Management sold 11,069 IGM Biosciences shares in Q2 2025, an estimated $12.7K.
  • INTECH Investment Management first reported a position in IGM Biosciences in Q1 2025 and held it in 1 quarter.
  • INTECH Investment Management's IGM Biosciences position peaked at $12.7K in Q1 2025.
  • 66 funds tracked by Wall St. Rank held IGM Biosciences as of Q2 2025.

Based on INTECH Investment Management's 13F filing for Q2 2025, filed 8 Aug 2025.